{
  "version": "1",
  "license": "https://creativecommons.org/licenses/by/4.0/",
  "count": 53,
  "records": [
    {
      "id": "ic-a1",
      "version": "1",
      "drug": {
        "slug": "glp-1-agonists",
        "display": "GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide)"
      },
      "supplement": {
        "slug": "berberine",
        "display": "Berberine"
      },
      "severity": "moderate",
      "evidenceTier": "pharmacology-standard",
      "mechanism": "Both lower blood glucose through different pathways: GLP-1 agonists via the incretin signal and appetite, berberine via insulin sensitivity and AMPK. The concern is additive glucose lowering, primarily when insulin or a sulfonylurea is also part of the regimen.",
      "patientNotes": [
        "Do not add berberine on top of a GLP-1 medication without telling your prescriber.",
        "If your doctor approves, glucose monitoring may need to be more frequent."
      ],
      "pmids": [
        "41543854"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/41543854/"
      ],
      "guideSlugs": [
        "berberine-with-semaglutide",
        "berberine-vs-ozempic",
        "glp-1-companion-supplements"
      ],
      "guideUrls": [
        "https://supplementbrief.com/berberine-with-semaglutide/",
        "https://supplementbrief.com/berberine-vs-ozempic/",
        "https://supplementbrief.com/glp-1-companion-supplements/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/glp-1-agonists/berberine/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-09-05",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-a1.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-a1/"
    },
    {
      "id": "ic-a2",
      "version": "1",
      "drug": {
        "slug": "metformin",
        "display": "Metformin"
      },
      "supplement": {
        "slug": "berberine",
        "display": "Berberine"
      },
      "severity": "moderate",
      "evidenceTier": "pharmacology-standard",
      "mechanism": "Both improve insulin sensitivity and lower glucose; meta-analyses show each works alone, and together the glucose-lowering can add up, especially with other diabetes drugs in the mix.",
      "patientNotes": [
        "Discuss berberine with your prescriber before starting it alongside metformin.",
        "Watch for dizziness, sweating, or unusual weakness, and report them promptly."
      ],
      "pmids": [
        "32379652",
        "25498346"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/32379652/",
        "https://pubmed.ncbi.nlm.nih.gov/25498346/"
      ],
      "guideSlugs": [
        "berberine-vs-ozempic"
      ],
      "guideUrls": [
        "https://supplementbrief.com/berberine-vs-ozempic/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/metformin/berberine/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-08-18",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-a2.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-a2/"
    },
    {
      "id": "ic-a3a",
      "version": "1",
      "drug": {
        "slug": "insulin",
        "display": "Insulin"
      },
      "supplement": {
        "slug": "berberine",
        "display": "Berberine"
      },
      "severity": "major",
      "evidenceTier": "pharmacology-standard",
      "mechanism": "Insulin lowers glucose by design, with dose as the only lever. Berberine adds an independent glucose-lowering effect, so the risk of hypoglycemia on top of insulin is direct and clinically relevant.",
      "patientNotes": [
        "Do not start berberine while on insulin unless your prescriber explicitly approves.",
        "If approved, expect closer glucose checks; treat low-sugar symptoms as urgent."
      ],
      "pmids": [
        "25498346"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/25498346/"
      ],
      "guideSlugs": [
        "berberine-vs-ozempic",
        "berberine-with-semaglutide"
      ],
      "guideUrls": [
        "https://supplementbrief.com/berberine-vs-ozempic/",
        "https://supplementbrief.com/berberine-with-semaglutide/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/insulin/berberine/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-09-05",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-a3a.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-a3a/"
    },
    {
      "id": "ic-a3b",
      "version": "1",
      "drug": {
        "slug": "sulfonylureas",
        "display": "Sulfonylureas (glimepiride, gliclazide, glibenclamide)"
      },
      "supplement": {
        "slug": "berberine",
        "display": "Berberine"
      },
      "severity": "major",
      "evidenceTier": "pharmacology-standard",
      "mechanism": "Sulfonylureas push insulin release regardless of glucose level; berberine adds a separate glucose-lowering effect. Hypoglycemia risk is higher than with metformin monotherapy.",
      "patientNotes": [
        "Do not start berberine while on a sulfonylurea unless your prescriber explicitly approves.",
        "If approved, expect closer glucose checks; treat low-sugar symptoms as urgent."
      ],
      "pmids": [
        "25498346"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/25498346/"
      ],
      "guideSlugs": [
        "berberine-vs-ozempic",
        "berberine-with-semaglutide"
      ],
      "guideUrls": [
        "https://supplementbrief.com/berberine-vs-ozempic/",
        "https://supplementbrief.com/berberine-with-semaglutide/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/sulfonylureas/berberine/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-09-05",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-a3b.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-a3b/"
    },
    {
      "id": "ic-a4",
      "version": "1",
      "drug": {
        "slug": "glp-1-agonists",
        "display": "GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide)"
      },
      "supplement": {
        "slug": "chromium-picolinate",
        "display": "Chromium picolinate (200-1000 mcg/day)"
      },
      "severity": "caution",
      "evidenceTier": "pharmacology-standard",
      "mechanism": "Chromium may modestly improve insulin sensitivity; on top of a GLP-1 agonist a small additional glucose-lowering effect is theoretically possible. The evidence base is weaker than for berberine.",
      "patientNotes": [
        "Tell your prescriber you take chromium, especially if you have episodes of low blood sugar.",
        "Do not treat chromium as a substitute for glucose monitoring."
      ],
      "pmids": [
        "12664086"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/12664086/"
      ],
      "guideSlugs": [
        "glp-1-companion-supplements",
        "supplements-for-mirtazapine-weight-gain"
      ],
      "guideUrls": [
        "https://supplementbrief.com/glp-1-companion-supplements/",
        "https://supplementbrief.com/supplements-for-mirtazapine-weight-gain/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/glp-1-agonists/chromium-picolinate/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-08-18",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-a4.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-a4/"
    },
    {
      "id": "ic-a5a",
      "version": "1",
      "drug": {
        "slug": "insulin",
        "display": "Insulin"
      },
      "supplement": {
        "slug": "panax-ginseng",
        "display": "Panax ginseng (Korean red ginseng)"
      },
      "severity": "moderate",
      "evidenceTier": "pharmacology-standard",
      "mechanism": "Ginseng has been reported to lower postprandial glucose in controlled studies; combined with insulin the risk of hypoglycemia becomes clinically relevant because injected insulin has no glucose-sensing brake.",
      "patientNotes": [
        "Tell your prescriber if you take ginseng alongside insulin.",
        "Watch for symptoms of low blood sugar."
      ],
      "pmids": [
        "10761967",
        "14684758"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/10761967/",
        "https://pubmed.ncbi.nlm.nih.gov/14684758/"
      ],
      "guideSlugs": [
        "panax-ginseng-for-ed"
      ],
      "guideUrls": [
        "https://supplementbrief.com/panax-ginseng-for-ed/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/insulin/panax-ginseng/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-09-07",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-a5a.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-a5a/"
    },
    {
      "id": "ic-a5b",
      "version": "1",
      "drug": {
        "slug": "metformin",
        "display": "Metformin"
      },
      "supplement": {
        "slug": "panax-ginseng",
        "display": "Panax ginseng (Korean red ginseng)"
      },
      "severity": "caution",
      "evidenceTier": "pharmacology-standard",
      "mechanism": "Postprandial glucose effects of ginseng are small and inconsistent across preparations; with metformin alone the added hypoglycemia risk is low but not zero.",
      "patientNotes": [
        "Mention ginsenge use at your next diabetes review.",
        "No urgent action expected on metformin monotherapy; keep routine monitoring."
      ],
      "pmids": [
        "10761967"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/10761967/"
      ],
      "guideSlugs": [
        "panax-ginseng-for-ed"
      ],
      "guideUrls": [
        "https://supplementbrief.com/panax-ginseng-for-ed/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/metformin/panax-ginseng/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-08-18",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-a5b.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-a5b/"
    },
    {
      "id": "ic-a5c",
      "version": "1",
      "drug": {
        "slug": "sulfonylureas",
        "display": "Sulfonylureas (glimepiride, gliclazide, glibenclamide)"
      },
      "supplement": {
        "slug": "panax-ginseng",
        "display": "Panax ginseng (Korean red ginseng)"
      },
      "severity": "moderate",
      "evidenceTier": "pharmacology-standard",
      "mechanism": "Ginseng has been reported to lower postprandial glucose in controlled studies; combined with sulfonylureas the risk of hypoglycemia becomes clinically relevant because this class forces insulin release regardless of glucose level.",
      "patientNotes": [
        "Tell your prescriber if you take ginseng alongside a sulfonylurea.",
        "Watch for symptoms of low blood sugar."
      ],
      "pmids": [
        "10761967",
        "14684758"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/10761967/",
        "https://pubmed.ncbi.nlm.nih.gov/14684758/"
      ],
      "guideSlugs": [
        "panax-ginseng-for-ed"
      ],
      "guideUrls": [
        "https://supplementbrief.com/panax-ginseng-for-ed/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/sulfonylureas/panax-ginseng/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-09-07",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-a5c.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-a5c/"
    },
    {
      "id": "ic-a6",
      "version": "1",
      "drug": {
        "slug": "mirtazapine",
        "display": "Mirtazapine"
      },
      "supplement": {
        "slug": "berberine",
        "display": "Berberine"
      },
      "severity": "caution",
      "evidenceTier": "mechanistic",
      "mechanism": "Berberine inhibits CYP3A4 in vitro; mirtazapine is partly metabolized through CYP3A4, so blood levels of the antidepressant could shift. This is a metabolic flag, not a comment on mirtazapine effectiveness.",
      "patientNotes": [
        "Tell your psychiatrist or GP if you take both.",
        "Do not change your mirtazapine dose on your own."
      ],
      "pmids": [
        "21678521"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/21678521/"
      ],
      "guideSlugs": [
        "supplements-for-mirtazapine-weight-gain"
      ],
      "guideUrls": [
        "https://supplementbrief.com/supplements-for-mirtazapine-weight-gain/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/mirtazapine/berberine/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-08-18",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-a6.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-a6/"
    },
    {
      "id": "ic-b1",
      "version": "1",
      "drug": {
        "slug": "pde5-inhibitors",
        "display": "PDE5 inhibitors (sildenafil, tadalafil, vardenafil, avanafil)"
      },
      "supplement": {
        "slug": "l-citrulline",
        "display": "L-citrulline"
      },
      "severity": "moderate",
      "evidenceTier": "meta-rct",
      "mechanism": "Both act on the nitric oxide-cGMP axis: PDE5 inhibitors keep cGMP up, citrulline raises NO production. Additive vasodilation can drop blood pressure more than either alone.",
      "patientNotes": [
        "Ask your prescriber before combining them; monitoring blood pressure during use was the reviewer requirement.",
        "Dizziness here means a blood-pressure drop: if it happens after combining them, sit down and let your doctor know."
      ],
      "pmids": [
        "33587304",
        "21195829"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/33587304/",
        "https://pubmed.ncbi.nlm.nih.gov/21195829/"
      ],
      "guideSlugs": [
        "l-citrulline-vs-l-arginine-for-ed",
        "nitric-oxide-ed-supplements"
      ],
      "guideUrls": [
        "https://supplementbrief.com/l-citrulline-vs-l-arginine-for-ed/",
        "https://supplementbrief.com/nitric-oxide-ed-supplements/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/pde5-inhibitors/l-citrulline/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-08-18",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-b1.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-b1/"
    },
    {
      "id": "ic-b2",
      "version": "1",
      "drug": {
        "slug": "pde5-inhibitors",
        "display": "PDE5 inhibitors (sildenafil, tadalafil, vardenafil, avanafil)"
      },
      "supplement": {
        "slug": "l-arginine",
        "display": "L-arginine"
      },
      "severity": "moderate",
      "evidenceTier": "meta",
      "mechanism": "Same NO-cGMP pathway as citrulline; meta-analyses show the combination has been studied under supervision, but self-directed stacking carries additive hypotension risk.",
      "patientNotes": [
        "Same rule as citrulline: prescriber approval first, blood pressure monitoring during use.",
        "Report dizziness from a blood-pressure drop or near-fainting."
      ],
      "pmids": [
        "33587304"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/33587304/"
      ],
      "guideSlugs": [
        "l-citrulline-vs-l-arginine-for-ed",
        "nitric-oxide-ed-supplements"
      ],
      "guideUrls": [
        "https://supplementbrief.com/l-citrulline-vs-l-arginine-for-ed/",
        "https://supplementbrief.com/nitric-oxide-ed-supplements/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/pde5-inhibitors/l-arginine/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-08-18",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-b2.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-b2/"
    },
    {
      "id": "ic-b3",
      "version": "1",
      "drug": {
        "slug": "nitrates",
        "display": "Nitrates (nitroglycerin, isosorbide mono/dinitrate)"
      },
      "supplement": {
        "slug": "l-citrulline",
        "display": "L-citrulline"
      },
      "severity": "moderate",
      "evidenceTier": "pharmacology-standard",
      "mechanism": "Nitrates donate NO directly; adding an NO precursor can extend and amplify vasodilation. Citrulline can lower blood pressure on its own, so the combination is not automatically safe even though it is not a formal contraindication like PDE5 inhibitors with nitrates.",
      "patientNotes": [
        "Do not add citrulline while on nitroglycerin or isosorbide without your cardiologist.",
        "Blood pressure monitoring during use was the reviewer requirement."
      ],
      "pmids": [],
      "pubmedUrls": [],
      "guideSlugs": [
        "nitric-oxide-ed-supplements"
      ],
      "guideUrls": [
        "https://supplementbrief.com/nitric-oxide-ed-supplements/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/nitrates/l-citrulline/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-08-18",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-b3.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-b3/"
    },
    {
      "id": "ic-b4",
      "version": "1",
      "drug": {
        "slug": "nitrates",
        "display": "Nitrates (nitroglycerin, isosorbide mono/dinitrate)"
      },
      "supplement": {
        "slug": "l-arginine",
        "display": "L-arginine"
      },
      "severity": "moderate",
      "evidenceTier": "meta-pharmacology",
      "mechanism": "Arginine is the direct NO substrate; with nitrates the vasodilatory load stacks, and arginine infusions are known to lower blood pressure on their own.",
      "patientNotes": [
        "Same caution as citrulline with nitrates: cardiologist decision, blood pressure monitoring.",
        "Treat lightheadedness as a signal to stop and call."
      ],
      "pmids": [
        "33587304"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/33587304/"
      ],
      "guideSlugs": [
        "nitric-oxide-ed-supplements"
      ],
      "guideUrls": [
        "https://supplementbrief.com/nitric-oxide-ed-supplements/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/nitrates/l-arginine/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-08-18",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-b4.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-b4/"
    },
    {
      "id": "ic-b5a",
      "version": "1",
      "drug": {
        "slug": "minoxidil-oral",
        "display": "Minoxidil, oral (off-label)"
      },
      "supplement": {
        "slug": "ashwagandha",
        "display": "Ashwagandha"
      },
      "severity": "moderate",
      "evidenceTier": "pharmacology-standard",
      "mechanism": "Oral minoxidil is a systemic antihypertensive by origin and lowers blood pressure by design. Ashwagandha reduced blood pressure in randomized trials, so additive hypotension is plausible.",
      "patientNotes": [
        "Tell your prescriber you use ashwagandha alongside minoxidil.",
        "Report dizziness or unusually low blood pressure readings."
      ],
      "pmids": [
        "23439798"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/23439798/"
      ],
      "guideSlugs": [
        "nutrafol-vs-minoxidil"
      ],
      "guideUrls": [
        "https://supplementbrief.com/nutrafol-vs-minoxidil/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/minoxidil-oral/ashwagandha/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-09-05",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-b5a.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-b5a/"
    },
    {
      "id": "ic-b5b",
      "version": "1",
      "drug": {
        "slug": "minoxidil-topical",
        "display": "Minoxidil, topical"
      },
      "supplement": {
        "slug": "ashwagandha",
        "display": "Ashwagandha"
      },
      "severity": "caution",
      "evidenceTier": "pharmacology-standard",
      "mechanism": "Topical minoxidil absorbs systemically only in small amounts, so the blood-pressure effect is weaker and less predictable than with the oral form. The concern is low-grade rather than absent.",
      "patientNotes": [
        "Tell your prescriber you use ashwagandha alongside minoxidil.",
        "Report dizziness or unusually low blood pressure readings."
      ],
      "pmids": [
        "23439798"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/23439798/"
      ],
      "guideSlugs": [
        "nutrafol-vs-minoxidil"
      ],
      "guideUrls": [
        "https://supplementbrief.com/nutrafol-vs-minoxidil/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/minoxidil-topical/ashwagandha/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-09-05",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-b5b.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-b5b/"
    },
    {
      "id": "ic-b6",
      "version": "1",
      "drug": {
        "slug": "beta-blockers",
        "display": "Beta-blockers (propranolol, metoprolol, bisoprolol)"
      },
      "supplement": {
        "slug": "caffeine-egcg",
        "display": "High-dose caffeine or green tea extract (300-400 mg+/day from supplements)"
      },
      "severity": "caution",
      "evidenceTier": "pharmacology-standard",
      "mechanism": "Beta-blockers hold heart rate and blood pressure down; high-dose stimulant stacks push the cardiovascular system the other way. Palpitations and blood pressure swings are the practical concern.",
      "patientNotes": [
        "Do not mix stimulant-based fat burners with beta-blockers without your doctor.",
        "Keep an eye on pulse and blood pressure if you use caffeine-heavy supplements."
      ],
      "pmids": [],
      "pubmedUrls": [],
      "guideSlugs": [
        "supplements-for-mirtazapine-weight-gain"
      ],
      "guideUrls": [
        "https://supplementbrief.com/supplements-for-mirtazapine-weight-gain/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/beta-blockers/caffeine-egcg/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-08-18",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-b6.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-b6/"
    },
    {
      "id": "ic-c1",
      "version": "1",
      "drug": {
        "slug": "warfarin",
        "display": "Warfarin"
      },
      "supplement": {
        "slug": "vitamin-k",
        "display": "Vitamin K supplement (not dietary greens)"
      },
      "severity": "major",
      "evidenceTier": "cochrane-rct",
      "mechanism": "Vitamin K directly antagonizes warfarin mechanism. Starting or stopping a K supplement shifts INR, and variability itself raises risk on both sides: clotting and bleeding.",
      "patientNotes": [
        "Do not start or stop a vitamin K supplement on warfarin without your anticoagulation clinic.",
        "Consistency matters more than more-or-less."
      ],
      "pmids": [
        "24832594",
        "27346552"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/24832594/",
        "https://pubmed.ncbi.nlm.nih.gov/27346552/"
      ],
      "guideSlugs": [],
      "guideUrls": [],
      "pairUrl": "https://supplementbrief.com/interactions/warfarin/vitamin-k/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-08-18",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-c1.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-c1/"
    },
    {
      "id": "ic-c10",
      "version": "1",
      "drug": {
        "slug": "antiplatelets",
        "display": "Antiplatelets (aspirin, clopidogrel)"
      },
      "supplement": {
        "slug": "ginkgo-biloba",
        "display": "Ginkgo biloba"
      },
      "severity": "moderate",
      "evidenceTier": "case-cohort",
      "mechanism": "Case reports and cohort signals document spontaneous bleeding with ginkgo; on dual pathway antiplatelets the added risk is clinically relevant.",
      "patientNotes": [
        "Do not start ginkgo on aspirin or clopidogrel without a doctor decision.",
        "Treat any unusual bleeding as urgent."
      ],
      "pmids": [
        "16050865",
        "26958257"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/16050865/",
        "https://pubmed.ncbi.nlm.nih.gov/26958257/"
      ],
      "guideSlugs": [
        "supplements-for-ssri-induced-ed"
      ],
      "guideUrls": [
        "https://supplementbrief.com/supplements-for-ssri-induced-ed/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/antiplatelets/ginkgo-biloba/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-08-18",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-c10.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-c10/"
    },
    {
      "id": "ic-c11",
      "version": "1",
      "drug": {
        "slug": "antiplatelets",
        "display": "Antiplatelets (aspirin, clopidogrel)"
      },
      "supplement": {
        "slug": "omega-3-high-dose",
        "display": "High-dose fish oil (3 g+ EPA+DHA per day)"
      },
      "severity": "caution",
      "evidenceTier": "label-mechanistic",
      "mechanism": "Same antiplatelet mechanism as with anticoagulants, graded lower because the reviewed evidence did not show significant outcome changes.",
      "patientNotes": [
        "Mention it to your prescriber, especially before procedures.",
        "Keep the dose consistent."
      ],
      "pmids": [
        "27657121"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/27657121/"
      ],
      "guideSlugs": [
        "omega-3-for-inflammation"
      ],
      "guideUrls": [
        "https://supplementbrief.com/omega-3-for-inflammation/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/antiplatelets/omega-3-high-dose/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-08-18",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-c11.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-c11/"
    },
    {
      "id": "ic-c12a",
      "version": "1",
      "drug": {
        "slug": "warfarin",
        "display": "Warfarin"
      },
      "supplement": {
        "slug": "panax-ginseng",
        "display": "Panax ginseng (Korean red ginseng)"
      },
      "severity": "caution",
      "evidenceTier": "rct",
      "mechanism": "A randomized trial in patients with cardiovascular disease found Korean red ginseng did not significantly change INR with warfarin; case-based concerns remain, so the level is low but documented.",
      "patientNotes": [
        "Tell your anticoagulation clinic about ginseng.",
        "Keep INR checks on schedule when anything in your routine changes."
      ],
      "pmids": [
        "19913311"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/19913311/"
      ],
      "guideSlugs": [
        "panax-ginseng-for-ed"
      ],
      "guideUrls": [
        "https://supplementbrief.com/panax-ginseng-for-ed/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/warfarin/panax-ginseng/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-08-18",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-c12a.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-c12a/"
    },
    {
      "id": "ic-c12b",
      "version": "1",
      "drug": {
        "slug": "doacs",
        "display": "DOACs (apixaban, rivaroxaban, dabigatran, edoxaban)"
      },
      "supplement": {
        "slug": "panax-ginseng",
        "display": "Panax ginseng (Korean red ginseng)"
      },
      "severity": "caution",
      "evidenceTier": "mechanistic",
      "mechanism": "Case reports describe INR changes and bleeding with ginseng on anticoagulants; without a warfarin-style INR window on DOACs, the practical level stays low-caution. The cited anchor is the warfarin-by-ginseng interaction RCT; on DOACs the borrowing is class-level context, not a trial of this pair.",
      "patientNotes": [
        "Mention ginseng to your prescriber.",
        "Report bruising or bleeding."
      ],
      "pmids": [
        "19913311"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/19913311/"
      ],
      "guideSlugs": [
        "panax-ginseng-for-ed"
      ],
      "guideUrls": [
        "https://supplementbrief.com/panax-ginseng-for-ed/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/doacs/panax-ginseng/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-09-25",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-c12b.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-c12b/"
    },
    {
      "id": "ic-c12c",
      "version": "1",
      "drug": {
        "slug": "antiplatelets",
        "display": "Antiplatelets (aspirin, clopidogrel)"
      },
      "supplement": {
        "slug": "panax-ginseng",
        "display": "Panax ginseng (Korean red ginseng)"
      },
      "severity": "caution",
      "evidenceTier": "mechanistic",
      "mechanism": "Ginseng bleeding case reports exist on antithrombotic therapy overall; on antiplatelets the documented concern is low-grade. The cited anchor is the warfarin-by-ginseng interaction RCT; on antiplatelets the borrowing is class-level context, not a trial of this pair.",
      "patientNotes": [
        "Tell your doctor about ginseng use.",
        "Watch for bleeding signs."
      ],
      "pmids": [
        "19913311"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/19913311/"
      ],
      "guideSlugs": [
        "panax-ginseng-for-ed"
      ],
      "guideUrls": [
        "https://supplementbrief.com/panax-ginseng-for-ed/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/antiplatelets/panax-ginseng/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-09-25",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-c12c.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-c12c/"
    },
    {
      "id": "ic-c2",
      "version": "1",
      "drug": {
        "slug": "warfarin",
        "display": "Warfarin"
      },
      "supplement": {
        "slug": "garlic",
        "display": "Garlic extract (allicin or aged garlic)"
      },
      "severity": "moderate",
      "evidenceTier": "mechanistic-ehr",
      "mechanism": "Garlic inhibits platelet aggregation, which adds to warfarin anticoagulation rather than opposing it; electronic health record screening flags garlic among warfarin-relevant supplements.",
      "patientNotes": [
        "Tell your anticoagulation team about garlic supplements.",
        "Report unusual bruising or bleeding."
      ],
      "pmids": [
        "27766480",
        "29295118"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/27766480/",
        "https://pubmed.ncbi.nlm.nih.gov/29295118/"
      ],
      "guideSlugs": [],
      "guideUrls": [],
      "pairUrl": "https://supplementbrief.com/interactions/warfarin/garlic/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-08-18",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-c2.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-c2/"
    },
    {
      "id": "ic-c3",
      "version": "1",
      "drug": {
        "slug": "warfarin",
        "display": "Warfarin"
      },
      "supplement": {
        "slug": "ginkgo-biloba",
        "display": "Ginkgo biloba"
      },
      "severity": "major",
      "evidenceTier": "cohort-case",
      "mechanism": "Ginkgo antagonists platelet-activating factor and case reports plus a large VA cohort show elevated bleeding signals (HR 1.38) with warfarin.",
      "patientNotes": [
        "Do not combine ginkgo with warfarin unless your prescriber explicitly decides to.",
        "Any unusual bleeding is a same-day call."
      ],
      "pmids": [
        "26958257",
        "9633781",
        "16050865"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/26958257/",
        "https://pubmed.ncbi.nlm.nih.gov/9633781/",
        "https://pubmed.ncbi.nlm.nih.gov/16050865/"
      ],
      "guideSlugs": [
        "supplements-for-ssri-induced-ed"
      ],
      "guideUrls": [
        "https://supplementbrief.com/supplements-for-ssri-induced-ed/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/warfarin/ginkgo-biloba/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-08-18",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-c3.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-c3/"
    },
    {
      "id": "ic-c4",
      "version": "1",
      "drug": {
        "slug": "warfarin",
        "display": "Warfarin"
      },
      "supplement": {
        "slug": "omega-3-high-dose",
        "display": "High-dose fish oil (3 g+ EPA+DHA per day)"
      },
      "severity": "caution",
      "evidenceTier": "retrospective",
      "mechanism": "High omega-3 doses reduce platelet aggregation; a retrospective cohort of fish oil with warfarin found no significant INR or adverse-event change, so the documented concern is low-grade.",
      "patientNotes": [
        "Mention high-dose fish oil at INR checks.",
        "Keep the dose stable rather than on-and-off."
      ],
      "pmids": [
        "27657121"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/27657121/"
      ],
      "guideSlugs": [
        "omega-3-for-inflammation"
      ],
      "guideUrls": [
        "https://supplementbrief.com/omega-3-for-inflammation/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/warfarin/omega-3-high-dose/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-08-18",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-c4.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-c4/"
    },
    {
      "id": "ic-c5",
      "version": "1",
      "drug": {
        "slug": "warfarin",
        "display": "Warfarin"
      },
      "supplement": {
        "slug": "vitamin-e-high-dose",
        "display": "Vitamin E, high dose (400 IU+/day)"
      },
      "severity": "moderate",
      "evidenceTier": "cohort",
      "mechanism": "High-dose vitamin E has antiplatelet-type effects; higher serum vitamin E tracks with bleeding risk in patients on oral anticoagulants.",
      "patientNotes": [
        "High-dose vitamin E on warfarin only after agreement with your prescriber.",
        "Report bruising or bleeding changes."
      ],
      "pmids": [
        "24166490"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/24166490/"
      ],
      "guideSlugs": [],
      "guideUrls": [],
      "pairUrl": "https://supplementbrief.com/interactions/warfarin/vitamin-e-high-dose/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-08-18",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-c5.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-c5/"
    },
    {
      "id": "ic-c6",
      "version": "1",
      "drug": {
        "slug": "doacs",
        "display": "DOACs (apixaban, rivaroxaban, dabigatran, edoxaban)"
      },
      "supplement": {
        "slug": "garlic",
        "display": "Garlic extract"
      },
      "severity": "moderate",
      "evidenceTier": "label-mechanistic",
      "mechanism": "DOAC labels warn about bleeding with antiplatelet herbs; garlic inhibits platelet aggregation by changing platelet function.",
      "patientNotes": [
        "Tell your prescriber about garlic supplements on a DOAC.",
        "Report unusual bruising or bleeding."
      ],
      "pmids": [
        "27766480"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/27766480/"
      ],
      "guideSlugs": [],
      "guideUrls": [],
      "pairUrl": "https://supplementbrief.com/interactions/doacs/garlic/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-08-18",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-c6.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-c6/"
    },
    {
      "id": "ic-c7",
      "version": "1",
      "drug": {
        "slug": "doacs",
        "display": "DOACs (apixaban, rivaroxaban, dabigatran, edoxaban)"
      },
      "supplement": {
        "slug": "ginkgo-biloba",
        "display": "Ginkgo biloba"
      },
      "severity": "moderate",
      "evidenceTier": "label-mechanistic",
      "mechanism": "The bleeding mechanism documented for ginkgo with warfarin applies without an INR to watch; DOAC monitoring is harder, which raises practical caution.",
      "patientNotes": [
        "Avoid ginkgo on a DOAC unless your prescriber says otherwise.",
        "Bleeding signs deserve a prompt call."
      ],
      "pmids": [
        "26958257"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/26958257/"
      ],
      "guideSlugs": [],
      "guideUrls": [],
      "pairUrl": "https://supplementbrief.com/interactions/doacs/ginkgo-biloba/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-08-18",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-c7.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-c7/"
    },
    {
      "id": "ic-c8",
      "version": "1",
      "drug": {
        "slug": "doacs",
        "display": "DOACs (apixaban, rivaroxaban, dabigatran, edoxaban)"
      },
      "supplement": {
        "slug": "omega-3-high-dose",
        "display": "High-dose fish oil (3 g+ EPA+DHA per day)"
      },
      "severity": "caution",
      "evidenceTier": "label-mechanistic",
      "mechanism": "Antiplatelet effect of high-dose omega-3 adds to anticoagulation; the direct warfarin cohort found no significant signal, and no comparable DOAC-specific cohort exists.",
      "patientNotes": [
        "Mention high-dose fish oil to your prescriber.",
        "Keep intake stable."
      ],
      "pmids": [
        "27657121"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/27657121/"
      ],
      "guideSlugs": [
        "omega-3-for-inflammation"
      ],
      "guideUrls": [
        "https://supplementbrief.com/omega-3-for-inflammation/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/doacs/omega-3-high-dose/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-08-18",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-c8.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-c8/"
    },
    {
      "id": "ic-c9",
      "version": "1",
      "drug": {
        "slug": "antiplatelets",
        "display": "Antiplatelets (aspirin, clopidogrel)"
      },
      "supplement": {
        "slug": "garlic",
        "display": "Garlic extract"
      },
      "severity": "moderate",
      "evidenceTier": "mechanistic-comparative",
      "mechanism": "Garlic tablets show measurable antiplatelet activity in comparative studies with aspirin; stacked on aspirin or clopidogrel the antiplatelet load adds up.",
      "patientNotes": [
        "Discuss garlic with your prescriber on antiplatelet therapy.",
        "Watch for bruising, nosebleeds, or dark stools."
      ],
      "pmids": [
        "27766480",
        "27761425"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/27766480/",
        "https://pubmed.ncbi.nlm.nih.gov/27761425/"
      ],
      "guideSlugs": [],
      "guideUrls": [],
      "pairUrl": "https://supplementbrief.com/interactions/antiplatelets/garlic/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-08-18",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-c9.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-c9/"
    },
    {
      "id": "ic-d1",
      "version": "1",
      "drug": {
        "slug": "statins-any",
        "display": "Statins (any)"
      },
      "supplement": {
        "slug": "red-yeast-rice",
        "display": "Red yeast rice (monacolin K)"
      },
      "severity": "major",
      "evidenceTier": "case-reports-review",
      "mechanism": "Monacolin K is lovastatin identical: adding red yeast rice to a statin is two statins at once, and the monacolin K content of these products varies widely from bottle to bottle. Documented outcomes include severe rhabdomyolysis with kidney injury.",
      "patientNotes": [
        "Do not take red yeast rice alongside any statin.",
        "Muscle pain, weakness, or dark urine on this combination is an urgent symptom."
      ],
      "pmids": [
        "40909457",
        "37831308"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/40909457/",
        "https://pubmed.ncbi.nlm.nih.gov/37831308/"
      ],
      "guideSlugs": [],
      "guideUrls": [],
      "pairUrl": "https://supplementbrief.com/interactions/statins-any/red-yeast-rice/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-09-05",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-d1.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-d1/"
    },
    {
      "id": "ic-d2a",
      "version": "1",
      "drug": {
        "slug": "statins-cyp3a4",
        "display": "Simvastatin or lovastatin"
      },
      "supplement": {
        "slug": "grapefruit-bergamot",
        "display": "Grapefruit or bergamot extract"
      },
      "severity": "major",
      "evidenceTier": "review",
      "mechanism": "Grapefruit juice blocks intestinal CYP3A4 and raises simvastatin and lovastatin exposure several-fold, the best-documented food-drug interaction in this class. The direct interaction evidence is almost entirely from grapefruit juice; bergamot extracts vary in composition.",
      "patientNotes": [
        "Avoid grapefruit and bergamot products on simvastatin or lovastatin unless your doctor says otherwise.",
        "This is a daily-intake problem, not just an occasional one."
      ],
      "pmids": [
        "26299317"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/26299317/"
      ],
      "guideSlugs": [],
      "guideUrls": [],
      "pairUrl": "https://supplementbrief.com/interactions/statins-cyp3a4/grapefruit-bergamot/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-09-05",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-d2a.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-d2a/"
    },
    {
      "id": "ic-d2b",
      "version": "1",
      "drug": {
        "slug": "atorvastatin",
        "display": "Atorvastatin"
      },
      "supplement": {
        "slug": "grapefruit-bergamot",
        "display": "Grapefruit or bergamot extract"
      },
      "severity": "moderate",
      "evidenceTier": "review",
      "mechanism": "Atorvastatin is CYP3A4-dependent but less so than simvastatin; grapefruit raises levels to a smaller degree, so the concern is real but graded lower. The direct interaction evidence is almost entirely from grapefruit juice; bergamot extracts vary in composition.",
      "patientNotes": [
        "Limit grapefruit intake on atorvastatin and mention it at review.",
        "Rosuvastatin and pravastatin are the lower-risk statins here."
      ],
      "pmids": [
        "26299317"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/26299317/"
      ],
      "guideSlugs": [],
      "guideUrls": [],
      "pairUrl": "https://supplementbrief.com/interactions/atorvastatin/grapefruit-bergamot/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-09-05",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-d2b.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-d2b/"
    },
    {
      "id": "ic-d3",
      "version": "1",
      "drug": {
        "slug": "statins-any",
        "display": "Statins (any)"
      },
      "supplement": {
        "slug": "niacin-high-dose",
        "display": "Niacin, high dose (1 g+/day)"
      },
      "severity": "moderate",
      "evidenceTier": "pharmacology-standard",
      "mechanism": "Statin plus high-dose niacin raises myopathy and hepatotoxicity risk; the large outcome trials that combined them did so under lipid-specialist supervision with lab monitoring.",
      "patientNotes": [
        "High-dose niacin with a statin only under specialist supervision.",
        "New muscle pain or weakness while on both is a call-your-doctor symptom."
      ],
      "pmids": [],
      "pubmedUrls": [],
      "guideSlugs": [],
      "guideUrls": [],
      "pairUrl": "https://supplementbrief.com/interactions/statins-any/niacin-high-dose/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-08-18",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-d3.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-d3/"
    },
    {
      "id": "ic-d4a",
      "version": "1",
      "drug": {
        "slug": "felodipine-nifedipine",
        "display": "Felodipine or nifedipine"
      },
      "supplement": {
        "slug": "grapefruit-bergamot",
        "display": "Grapefruit or bergamot extract"
      },
      "severity": "major",
      "evidenceTier": "pk-model",
      "mechanism": "Felodipine and nifedipine are CYP3A4 substrates with documented grapefruit exposure increases; pharmacokinetic modeling puts them among the most affected drugs. The direct interaction evidence is almost entirely from grapefruit juice; bergamot extracts vary in composition.",
      "patientNotes": [
        "Avoid grapefruit juice and bergamot on felodipine or nifedipine.",
        "Excess low blood pressure or ankle swelling deserves a call."
      ],
      "pmids": [
        "24898424"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/24898424/"
      ],
      "guideSlugs": [],
      "guideUrls": [],
      "pairUrl": "https://supplementbrief.com/interactions/felodipine-nifedipine/grapefruit-bergamot/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-09-05",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-d4a.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-d4a/"
    },
    {
      "id": "ic-d4b",
      "version": "1",
      "drug": {
        "slug": "amlodipine",
        "display": "Amlodipine"
      },
      "supplement": {
        "slug": "grapefruit-bergamot",
        "display": "Grapefruit or bergamot extract"
      },
      "severity": "moderate",
      "evidenceTier": "pk-model",
      "mechanism": "Amlodipine is CYP3A4-metabolized but slower; grapefruit interaction is measurable yet smaller than with felodipine or nifedipine. The direct interaction evidence is almost entirely from grapefruit juice; bergamot extracts vary in composition.",
      "patientNotes": [
        "Discuss grapefruit intake with your cardiologist on amlodipine.",
        "Report dizziness or swelling changes."
      ],
      "pmids": [
        "24898424"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/24898424/"
      ],
      "guideSlugs": [],
      "guideUrls": [],
      "pairUrl": "https://supplementbrief.com/interactions/amlodipine/grapefruit-bergamot/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-09-05",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-d4b.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-d4b/"
    },
    {
      "id": "ic-e1",
      "version": "1",
      "drug": {
        "slug": "ace-inhibitors-arbs",
        "display": "ACE inhibitors or ARBs (lisinopril, enalapril, losartan, valsartan)"
      },
      "supplement": {
        "slug": "potassium",
        "display": "Potassium supplement (chloride or other)"
      },
      "severity": "major",
      "evidenceTier": "pharmacology-standard",
      "mechanism": "ACE inhibitors and ARBs lower aldosterone, which normally excretes potassium; adding a potassium supplement can push serum potassium into the arrhythmia range, especially with kidney disease or diabetes.",
      "patientNotes": [
        "Do not take potassium supplements on an ACE inhibitor or ARB without a doctor order and a potassium level.",
        "This combination is standard pharmacology, not a theoretical edge case."
      ],
      "pmids": [],
      "pubmedUrls": [],
      "guideSlugs": [
        "electrolytes-on-ozempic"
      ],
      "guideUrls": [
        "https://supplementbrief.com/electrolytes-on-ozempic/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/ace-inhibitors-arbs/potassium/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-08-18",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-e1.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-e1/"
    },
    {
      "id": "ic-e2",
      "version": "1",
      "drug": {
        "slug": "spironolactone",
        "display": "Spironolactone"
      },
      "supplement": {
        "slug": "potassium",
        "display": "Potassium supplement"
      },
      "severity": "major",
      "evidenceTier": "pharmacology-standard",
      "mechanism": "Spironolactone is potassium-sparing by design; adding potassium on top is the textbook hyperkalemia setup.",
      "patientNotes": [
        "Potassium with spironolactone only if explicitly prescribed.",
        "Never self-start potassium tablets on this drug."
      ],
      "pmids": [],
      "pubmedUrls": [],
      "guideSlugs": [
        "electrolytes-on-ozempic"
      ],
      "guideUrls": [
        "https://supplementbrief.com/electrolytes-on-ozempic/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/spironolactone/potassium/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-08-18",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-e2.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-e2/"
    },
    {
      "id": "ic-e3",
      "version": "1",
      "drug": {
        "slug": "ace-inhibitors-arbs",
        "display": "ACE inhibitors or ARBs (lisinopril, enalapril, losartan, valsartan)"
      },
      "supplement": {
        "slug": "licorice-root",
        "display": "Licorice root (glycyrrhizin)"
      },
      "severity": "moderate",
      "evidenceTier": "case-reports",
      "mechanism": "Glycyrrhizin produces pseudo-hyperaldosteronism: potassium loss and blood pressure rise, directly working against what ACE inhibitors and ARBs are prescribed for.",
      "patientNotes": [
        "Avoid licorice root supplements on blood pressure medication unless your doctor approves.",
        "Report muscle weakness or palpitations, which can accompany low potassium."
      ],
      "pmids": [
        "42367449"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/42367449/"
      ],
      "guideSlugs": [],
      "guideUrls": [],
      "pairUrl": "https://supplementbrief.com/interactions/ace-inhibitors-arbs/licorice-root/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-08-18",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-e3.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-e3/"
    },
    {
      "id": "ic-e4",
      "version": "1",
      "drug": {
        "slug": "digoxin",
        "display": "Digoxin"
      },
      "supplement": {
        "slug": "licorice-root",
        "display": "Licorice root (glycyrrhizin)"
      },
      "severity": "moderate",
      "evidenceTier": "case-reports",
      "mechanism": "Licorice-driven potassium loss increases digoxin toxicity risk; the narrow therapeutic window makes this a documented clinical concern.",
      "patientNotes": [
        "Do not take licorice while on digoxin.",
        "Tell your cardiologist about any licorice-containing supplement or tea."
      ],
      "pmids": [
        "42544526"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/42544526/"
      ],
      "guideSlugs": [],
      "guideUrls": [],
      "pairUrl": "https://supplementbrief.com/interactions/digoxin/licorice-root/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-08-18",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-e4.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-e4/"
    },
    {
      "id": "ic-e5",
      "version": "1",
      "drug": {
        "slug": "diuretics",
        "display": "Thiazide or loop diuretics (HCTZ, furosemide)"
      },
      "supplement": {
        "slug": "potassium",
        "display": "Potassium supplement"
      },
      "severity": "caution",
      "evidenceTier": "pharmacology-standard",
      "mechanism": "Loop and thiazide diuretics waste potassium, and doctors sometimes deliberately prescribe replacement; self-supplementing without a potassium level is the risk, not the combination itself.",
      "patientNotes": [
        "Potassium on a diuretic only by prescription and with lab checks.",
        "Report weakness or palpitations."
      ],
      "pmids": [],
      "pubmedUrls": [],
      "guideSlugs": [
        "electrolytes-on-ozempic"
      ],
      "guideUrls": [
        "https://supplementbrief.com/electrolytes-on-ozempic/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/diuretics/potassium/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-08-18",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-e5.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-e5/"
    },
    {
      "id": "ic-e6",
      "version": "1",
      "drug": {
        "slug": "diuretics",
        "display": "Thiazide or loop diuretics (HCTZ, furosemide)"
      },
      "supplement": {
        "slug": "magnesium",
        "display": "Magnesium, high dose"
      },
      "severity": "caution",
      "evidenceTier": "pharmacology-standard",
      "mechanism": "Diuretics waste magnesium, so replacement is often reasonable. With normal kidney function, hypermagnesemia from standard oral doses is rare, and high doses more often cause diarrhea. In chronic kidney disease the risk of magnesium accumulation, and with it hypermagnesemia, rises.",
      "patientNotes": [
        "Let your doctor pick the magnesium dose based on labs and kidney function.",
        "Report slow pulse, flushing, or confusion."
      ],
      "pmids": [],
      "pubmedUrls": [],
      "guideSlugs": [
        "electrolytes-on-ozempic"
      ],
      "guideUrls": [
        "https://supplementbrief.com/electrolytes-on-ozempic/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/diuretics/magnesium/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-09-05",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-e6.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-e6/"
    },
    {
      "id": "ic-f1",
      "version": "1",
      "drug": {
        "slug": "ppis",
        "display": "Proton pump inhibitors, long-term (omeprazole, pantoprazole)"
      },
      "supplement": {
        "slug": "magnesium",
        "display": "Magnesium supplement"
      },
      "severity": "caution",
      "evidenceTier": "review",
      "mechanism": "Long-term PPI use is a documented cause of low magnesium; supplementation is sometimes needed when symptoms or risk factors point there.",
      "patientNotes": [
        "On a PPI for months with cramps or rhythm symptoms, ask for a magnesium level before megadosing."
      ],
      "pmids": [
        "26981439"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/26981439/"
      ],
      "guideSlugs": [
        "magnesium-forms-compared"
      ],
      "guideUrls": [
        "https://supplementbrief.com/magnesium-forms-compared/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/ppis/magnesium/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-09-05",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-f1.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-f1/"
    },
    {
      "id": "ic-f2",
      "version": "1",
      "drug": {
        "slug": "any-oral-medication",
        "display": "Most oral medications"
      },
      "supplement": {
        "slug": "psyllium",
        "display": "Psyllium husk"
      },
      "severity": "caution",
      "evidenceTier": "pharmacology-standard",
      "mechanism": "Viscous fiber can slow absorption of pills taken at the same moment; this is a timing problem with a clean fix, not a prohibition.",
      "patientNotes": [
        "Take psyllium separately from your medications, usually about two hours before or after, unless your prescriber or the drug label says otherwise, with a full glass of water."
      ],
      "pmids": [],
      "pubmedUrls": [],
      "guideSlugs": [
        "constipation-on-glp1",
        "supplements-for-mirtazapine-weight-gain",
        "glp-1-companion-supplements"
      ],
      "guideUrls": [
        "https://supplementbrief.com/constipation-on-glp1/",
        "https://supplementbrief.com/supplements-for-mirtazapine-weight-gain/",
        "https://supplementbrief.com/glp-1-companion-supplements/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/any-oral-medication/psyllium/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-09-05",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-f2.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-f2/"
    },
    {
      "id": "ic-g1",
      "version": "1",
      "drug": {
        "slug": "ssris",
        "display": "SSRI antidepressants (sertraline, paroxetine, escitalopram)"
      },
      "supplement": {
        "slug": "st-johns-wort",
        "display": "St John's wort (Hypericum perforatum)"
      },
      "severity": "major",
      "evidenceTier": "case-reports-review",
      "mechanism": "Both substances push serotonin signaling: SSRIs block reuptake directly, and St John's wort is thought to add serotonergic activity of its own. Published case reports describe serotonin syndrome when the two were combined, with sertraline and paroxetine among the named drugs. No trial has stacked the two deliberately, and none should.",
      "patientNotes": [
        "Do not add St John's wort on top of an SSRI — this exact combination has published case reports of serotonin syndrome.",
        "If you already take both, watch for agitation, tremor, sweating, racing heart, fever, and muscle twitching: that cluster is a same-day medical conversation.",
        "Disclosure is the reader's part: every interaction on this page is invisible to a prescriber who does not know the herb is in the picture."
      ],
      "pmids": [
        "15916450"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/15916450/"
      ],
      "guideSlugs": [
        "st-johns-wort-with-antidepressants",
        "supplements-for-ssri-induced-ed"
      ],
      "guideUrls": [
        "https://supplementbrief.com/st-johns-wort-with-antidepressants/",
        "https://supplementbrief.com/supplements-for-ssri-induced-ed/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/ssris/st-johns-wort/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-09-12",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-g1.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-g1/"
    },
    {
      "id": "ic-g2",
      "version": "1",
      "drug": {
        "slug": "oral-contraceptives",
        "display": "Oral contraceptives (combined pill)"
      },
      "supplement": {
        "slug": "st-johns-wort",
        "display": "St John's wort (Hypericum perforatum)"
      },
      "severity": "moderate",
      "evidenceTier": "rct",
      "mechanism": "Hyperforin induces CYP3A4 and the P-glycoprotein transporter, which can speed the clearance of contraceptive steroid hormones. In a controlled trial of a hyperforin-rich extract, hormone exposure fell 13 to 15 percent with breakthrough bleeding and probable ovulation in some cycles; a low-hyperforin extract (Ze 117) stayed within bioequivalence limits. Labels do not disclose hyperforin content, so the buyer cannot tell which kind of extract is in the bottle.",
      "patientNotes": [
        "Because St John's wort can reduce the effectiveness of hormonal contraceptives, combining the two should include a conversation with your doctor about whether an additional method of contraception is needed.",
        "Breakthrough bleeding or spotting on the combination is a reason to use backup contraception and speak with your prescriber or pharmacist.",
        "The effect depends on the hyperforin content of the specific extract, which varies between products and batches and is not stated on labels."
      ],
      "pmids": [
        "15914127",
        "19015839"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/15914127/",
        "https://pubmed.ncbi.nlm.nih.gov/19015839/"
      ],
      "guideSlugs": [
        "semaglutide-birth-control",
        "st-johns-wort-with-antidepressants"
      ],
      "guideUrls": [
        "https://supplementbrief.com/semaglutide-birth-control/",
        "https://supplementbrief.com/st-johns-wort-with-antidepressants/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/oral-contraceptives/st-johns-wort/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-09-12",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-g2.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-g2/"
    },
    {
      "id": "ic-g3",
      "version": "1",
      "drug": {
        "slug": "warfarin",
        "display": "Warfarin"
      },
      "supplement": {
        "slug": "st-johns-wort",
        "display": "St John's wort (Hypericum perforatum)"
      },
      "severity": "major",
      "evidenceTier": "review",
      "mechanism": "Enzyme induction by hyperforin accelerates the metabolism of warfarin, pushing INR down below the protective window. Systematic reviews list warfarin among the drugs whose concentrations or effects fall on St John's wort, driven by the same CYP induction. The effect builds over days of continuous use and outlasts the last dose by one to two weeks.",
      "patientNotes": [
        "Do not start or stop St John's wort without telling your anticoagulation clinic — INR can drift down with no obvious dietary reason.",
        "If you have been taking both without the clinic knowing, request an INR check rather than adjusting the warfarin dose yourself.",
        "After stopping the herb, the induction fades over one to two weeks; keep the clinic informed through that window."
      ],
      "pmids": [
        "12392581"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/12392581/"
      ],
      "guideSlugs": [
        "st-johns-wort-with-antidepressants"
      ],
      "guideUrls": [
        "https://supplementbrief.com/st-johns-wort-with-antidepressants/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/warfarin/st-johns-wort/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-09-12",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-g3.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-g3/"
    },
    {
      "id": "ic-h1",
      "version": "1",
      "drug": {
        "slug": "glp-1-agonists",
        "display": "GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide)"
      },
      "supplement": {
        "slug": "oral-contraceptives",
        "display": "Oral contraceptives (combined pill)"
      },
      "severity": "moderate",
      "evidenceTier": "pk-study",
      "mechanism": "GLP-1 agonists slow gastric emptying, which can lower and delay the peak of pill hormones. For semaglutide the dedicated interaction study found bioequivalence held; for tirzepatide a single-dose study found hormone peaks roughly halved and the label added four-week barrier windows after each dose step. One class, two intensities.",
      "patientNotes": [
        "On tirzepatide (Mounjaro, Zepbound) with a pill: the label advises a non-oral method or backup contraception for four weeks after starting and after each dose increase.",
        "On injectable semaglutide (Ozempic, Wegovy) the dedicated study found no loss of pill exposure; a pharmacist conversation covers vomiting or diarrhea windows under your pill brand's missed-dose rules.",
        "Planning pregnancy: semaglutide is stopped at least two months ahead per the label."
      ],
      "pmids": [
        "25475122",
        "40330819",
        "42721915"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/25475122/",
        "https://pubmed.ncbi.nlm.nih.gov/40330819/",
        "https://pubmed.ncbi.nlm.nih.gov/42721915/"
      ],
      "guideSlugs": [
        "semaglutide-birth-control"
      ],
      "guideUrls": [
        "https://supplementbrief.com/semaglutide-birth-control/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/glp-1-agonists/oral-contraceptives/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-09-19",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-h1.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-h1/"
    },
    {
      "id": "ic-h2",
      "version": "1",
      "drug": {
        "slug": "oral-contraceptives",
        "display": "Oral contraceptives (combined pill)"
      },
      "supplement": {
        "slug": "berberine",
        "display": "Berberine"
      },
      "severity": "caution",
      "evidenceTier": "mechanistic",
      "mechanism": "Berberine inhibits CYP3A4 in vitro, the enzyme that clears ethinyl estradiol. The measured clinical anchor is transplant medicine (cyclosporine exposure up 34.5 percent); no contraceptive-specific human data exist. The concern is a plausible direction of changed exposure, not a measured effect.",
      "patientNotes": [
        "No measured effect of berberine on the pill exists; if you take both, a pharmacist conversation before stacking is the reasonable step.",
        "If your prescriber approves berberine on top of a GLP-1 medication, bring the pill into the same conversation."
      ],
      "pmids": [
        "42653808"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/42653808/"
      ],
      "guideSlugs": [
        "semaglutide-birth-control",
        "berberine-vs-ozempic"
      ],
      "guideUrls": [
        "https://supplementbrief.com/semaglutide-birth-control/",
        "https://supplementbrief.com/berberine-vs-ozempic/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/oral-contraceptives/berberine/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-09-19",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-h2.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-h2/"
    },
    {
      "id": "ic-h3",
      "version": "1",
      "drug": {
        "slug": "finasteride",
        "display": "Finasteride (Propecia, Proscar)"
      },
      "supplement": {
        "slug": "creatine",
        "display": "Creatine monohydrate"
      },
      "severity": "caution",
      "evidenceTier": "rct",
      "mechanism": "The hair-loss worry traces to one 2009 rugby study where DHT rose during loading, never replicated. The direct 2025 randomized trial in men on 5 g per day for 12 weeks measured hair counts and DHT with no effect on either, and on finasteride the type II conversion pathway the myth depends on is already inhibited.",
      "patientNotes": [
        "No documented interaction; the caution grade exists because the combination has been directly tested for hair outcomes and came back clean.",
        "If creatine is part of your training plan, it does not need to stop on finasteride."
      ],
      "pmids": [
        "40265319",
        "19741313"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/40265319/",
        "https://pubmed.ncbi.nlm.nih.gov/19741313/"
      ],
      "guideSlugs": [
        "finasteride-and-supplements"
      ],
      "guideUrls": [
        "https://supplementbrief.com/finasteride-and-supplements/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/finasteride/creatine/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-09-25",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-h3.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-h3/"
    },
    {
      "id": "ic-h4",
      "version": "1",
      "drug": {
        "slug": "finasteride",
        "display": "Finasteride (Propecia, Proscar)"
      },
      "supplement": {
        "slug": "ashwagandha",
        "display": "Ashwagandha root extract"
      },
      "severity": "caution",
      "evidenceTier": "rct",
      "mechanism": "Ashwagandha raises testosterone in several randomized trials, roughly 15 percent on average. A testosterone rise does not necessarily translate into more DHT while finasteride is suppressing the conversion, and no trial has measured hair outcomes on the combination.",
      "patientNotes": [
        "Tell your prescriber you take ashwagandha; the question is whether added androgen pressure belongs in your plan at all.",
        "No hair data exist for this pair; expect a conversation, not a research answer."
      ],
      "pmids": [
        "26609282",
        "30854916",
        "33150931"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/26609282/",
        "https://pubmed.ncbi.nlm.nih.gov/30854916/",
        "https://pubmed.ncbi.nlm.nih.gov/33150931/"
      ],
      "guideSlugs": [
        "finasteride-and-supplements"
      ],
      "guideUrls": [
        "https://supplementbrief.com/finasteride-and-supplements/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/finasteride/ashwagandha/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-09-25",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-h4.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-h4/"
    },
    {
      "id": "ic-h5",
      "version": "1",
      "drug": {
        "slug": "finasteride",
        "display": "Finasteride (Propecia, Proscar)"
      },
      "supplement": {
        "slug": "saw-palmetto",
        "display": "Saw palmetto (Serenoa repens)"
      },
      "severity": "caution",
      "evidenceTier": "rct",
      "mechanism": "Both act on 5-alpha reductase, finasteride potently and saw palmetto weakly. In the two-year head-to-head trial finasteride grew hair in 68 percent of men against 38 percent for saw palmetto, so the herb adds no documented benefit on top and muddies attribution if side effects appear.",
      "patientNotes": [
        "No trial tests saw palmetto added on top of finasteride; stacking a weak inhibitor onto a strong one has no documented upside.",
        "If you are considering replacing finasteride with saw palmetto, that is a prescriber conversation about efficacy, not a supplement swap."
      ],
      "pmids": [
        "23298508",
        "12006122",
        "19591529"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/23298508/",
        "https://pubmed.ncbi.nlm.nih.gov/12006122/",
        "https://pubmed.ncbi.nlm.nih.gov/19591529/"
      ],
      "guideSlugs": [
        "finasteride-and-supplements"
      ],
      "guideUrls": [
        "https://supplementbrief.com/finasteride-and-supplements/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/finasteride/saw-palmetto/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-09-25",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-h5.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-h5/"
    },
    {
      "id": "ic-i1",
      "version": "1",
      "drug": {
        "slug": "ssris",
        "display": "SSRI antidepressants (sertraline, paroxetine, escitalopram)"
      },
      "supplement": {
        "slug": "5-htp",
        "display": "5-HTP (5-hydroxytryptophan)"
      },
      "severity": "major",
      "evidenceTier": "pharmacology-standard",
      "mechanism": "SSRIs block serotonin reuptake. 5-HTP is a direct precursor of serotonin: it crosses the blood-brain barrier and is converted to serotonin. An open-label challenge in healthy Asian men found that a 200 mg dose of 5-HTP significantly augmented the prolactin and cortisol response to 20 mg of oral citalopram. Those hormone responses are the measured marker. One published case describes serotonin syndrome in a patient on sertraline who was in possession of more than 21 supplement products, 5-HTP among them. Another describes mania after 5-HTP was added to the MAOI phenelzine. That patient did not have clonus.",
      "patientNotes": [
        "Do not add 5-HTP on top of an SSRI on your own. Any dosing decision for something serotonergic belongs to your prescriber.",
        "If you already take both, watch for clonus, agitation, heavy sweating, tremor, hyperreflexia, hypertonicity, and a temperature above 38 °C. That cluster is a same-day medical conversation.",
        "Oral 5-HTP raises urinary 5-HIAA, the lab used to look for a carcinoid tumour. Mention the bottle to your prescriber and the lab before that result is read as a tumour signal."
      ],
      "pmids": [
        "16378695",
        "28839121",
        "21963353",
        "12925718",
        "18209781"
      ],
      "pubmedUrls": [
        "https://pubmed.ncbi.nlm.nih.gov/16378695/",
        "https://pubmed.ncbi.nlm.nih.gov/28839121/",
        "https://pubmed.ncbi.nlm.nih.gov/21963353/",
        "https://pubmed.ncbi.nlm.nih.gov/12925718/",
        "https://pubmed.ncbi.nlm.nih.gov/18209781/"
      ],
      "guideSlugs": [
        "5-htp-with-ssris",
        "winter-blues-supplements"
      ],
      "guideUrls": [
        "https://supplementbrief.com/5-htp-with-ssris/",
        "https://supplementbrief.com/winter-blues-supplements/"
      ],
      "pairUrl": "https://supplementbrief.com/interactions/ssris/5-htp/",
      "reviewedBy": "natallia-kalistratava",
      "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
      "lastVerified": "2026-11-14",
      "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-i1.json",
      "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-i1/"
    }
  ]
}
